The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the major lipid peroxidation project product hne preferentially forms dna addicts at codon 249 of the human p53 gene a unique mutational hot spot in hepatocellular liver carcinoma and it's been shown in other types of cancer as well
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
in cancer we have a gene called the tp3 cancer protection gene right it's the most common mutation seen in cancers 50 of camper cancers have a mutation in this gene hne induces this mutation and that's been shown in multiple different types of cancer
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.